VR Logo

TRACON Pharmaceuticals Inc. (TCON) download report


Healthcare | Biotechnology & Pharma Research

TRACON Pharmaceuticals Inc. (TCON) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer in the United States.

IPO Date: 30-Jan-2015

CEO, Pres & Director: Dr. Charles P. Theuer M.D., Ph.D.

Chief Financial Officer: Mr. Scott B. Brown CPA, M.S.

Listing: NASDAQ: TCON

Country: United States

Headquarters: San Diego, CA

Website: https://www.traconpharma.com

Key Facts

Market cap: $38.43 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-33.08 Mln

Cash: $16.64 Mln

Total Debt: $0.70 Mln

Insider's Holding: 8.86%

Liquidity: Low

52 Week range: $1.24 - 7.09

Shares outstanding: 20,079,500

10 Years Aggregate:

  • CFO: $-163.95 Mln
  • EBITDA: $-188.89 Mln
  • Net Profit: $-193.04 Mln

Stock Performance

Time Period TRACON Pharmaceuticals (TCON) S&P BSE Sensex* S&P Small-Cap 600*
YTD-27.08-8.48-19.22
1 month11.60-2.86-9.34
3 months-29.12-7.99-14.58
1 Year-70.891.45-17.64
3 Years-33.2810.615.91
5 Years-39.2911.565.64
10 Years--11.8310.10
As on 29-Jun-2022 *As on 30-Jun-2022
Year TRACON Pharmaceuticals (TCON) S&P Small-Cap 600 S&P BSE Sensex
2021-76.3225.2721.99
2020400.009.5715.75
2019-62.8620.8614.38
2018-81.02-9.705.87
2017-31.6311.7327.91
2016-46.9724.741.95